Open main menu

Pages with the most revisions

Showing below up to 100 results in range #101 to #200.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. Growth hormone (somatotropin)‏‎ (3 revisions)
  2. ICRP Publication 103‏‎ (3 revisions)
  3. Excretion rate (instantaneous)‏‎ (3 revisions)
  4. Fairness‏‎ (3 revisions)
  5. Absorption‏‎ (3 revisions)
  6. Recovery‏‎ (3 revisions)
  7. Gamma ray‏‎ (3 revisions)
  8. Spread-out Bragg peak‏‎ (3 revisions)
  9. DNA damage signalling‏‎ (3 revisions)
  10. Field-size effect (Volume effect)‏‎ (3 revisions)
  11. Gastrointestinal syndrome‏‎ (3 revisions)
  12. Biomedical research volunteer‏‎ (3 revisions)
  13. Cardiomyopathy‏‎ (3 revisions)
  14. Wisdom‏‎ (3 revisions)
  15. Dose equivalent‏‎ (3 revisions)
  16. Flexible tissues‏‎ (3 revisions)
  17. Guide to the System of Radiological Protection‏‎ (3 revisions)
  18. Autonomy‏‎ (3 revisions)
  19. Target region‏‎ (3 revisions)
  20. Dose limit‏‎ (3 revisions)
  21. Fluence‏‎ (3 revisions)
  22. Constancy test‏‎ (3 revisions)
  23. Dose‏‎ (3 revisions)
  24. Dose limits‏‎ (3 revisions)
  25. Fluoroscopically guided interventions‏‎ (3 revisions)
  26. Annual dose‏‎ (3 revisions)
  27. DS02‏‎ (3 revisions)
  28. Potential exposure‏‎ (3 revisions)
  29. Accountability‏‎ (3 revisions)
  30. Half-life, physical‏‎ (3 revisions)
  31. Rigidity threshold‏‎ (3 revisions)
  32. Cell death‏‎ (3 revisions)
  33. Low Earth orbit‏‎ (3 revisions)
  34. Contamination‏‎ (3 revisions)
  35. X ray‏‎ (3 revisions)
  36. Dose of record (E)‏‎ (3 revisions)
  37. Exponential survival curve‏‎ (3 revisions)
  38. Annual limit on intake‏‎ (3 revisions)
  39. Unsealed source‏‎ (3 revisions)
  40. Xerostomia‏‎ (3 revisions)
  41. Graded approach‏‎ (3 revisions)
  42. Interphase death‏‎ (3 revisions)
  43. Test‏‎ (3 revisions)
  44. Dose per content function‏‎ (3 revisions)
  45. Public exposure‏‎ (3 revisions)
  46. Equity‏‎ (3 revisions)
  47. Fractionation‏‎ (3 revisions)
  48. Uptake‏‎ (3 revisions)
  49. Active (red) bone marrow‏‎ (3 revisions)
  50. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  51. Utilitarian ethics‏‎ (3 revisions)
  52. Operational quantity‏‎ (3 revisions)
  53. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  54. Coster-Kronig transition‏‎ (3 revisions)
  55. Value judgement‏‎ (3 revisions)
  56. Gray‏‎ (3 revisions)
  57. Valvular heart disease‏‎ (3 revisions)
  58. Personal dose equivalent‏‎ (3 revisions)
  59. Principle of justification‏‎ (3 revisions)
  60. Emergency preparedness‏‎ (3 revisions)
  61. Radiofrequency ablation‏‎ (3 revisions)
  62. Representative organism (non-human biota)‏‎ (2 revisions)
  63. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  64. Beta-minus decay‏‎ (2 revisions)
  65. Clearance level‏‎ (2 revisions)
  66. Threshold dose for tissue reactions‏‎ (2 revisions)
  67. Magnetosphere‏‎ (2 revisions)
  68. Dose constraint‏‎ (2 revisions)
  69. Early normal tissue responses‏‎ (2 revisions)
  70. Radiographer‏‎ (2 revisions)
  71. Exposure situation‏‎ (2 revisions)
  72. Growth factor‏‎ (2 revisions)
  73. Alimentary tract transfer factor‏‎ (2 revisions)
  74. Representative person‏‎ (2 revisions)
  75. Safety‏‎ (2 revisions)
  76. Beta-plus decay‏‎ (2 revisions)
  77. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  78. Specific effective energy‏‎ (2 revisions)
  79. Limitation of dose‏‎ (2 revisions)
  80. Cumulative dose‏‎ (2 revisions)
  81. Transmission detection system‏‎ (2 revisions)
  82. Multistage tumorigenesis‏‎ (2 revisions)
  83. Non-sphericity parameter‏‎ (2 revisions)
  84. Dose conversion coefficient‏‎ (2 revisions)
  85. Pharynx‏‎ (2 revisions)
  86. Edema‏‎ (2 revisions)
  87. Excess relative risk‏‎ (2 revisions)
  88. Exposure to Radon at Home‏‎ (2 revisions)
  89. GATA binding protein 2‏‎ (2 revisions)
  90. Reproductive integrity‏‎ (2 revisions)
  91. Hormones‏‎ (2 revisions)
  92. Authorization‏‎ (2 revisions)
  93. Safety case‏‎ (2 revisions)
  94. Slow repair‏‎ (2 revisions)
  95. Isotropic geometry‏‎ (2 revisions)
  96. Clonogenic cells‏‎ (2 revisions)
  97. Lineal energy‏‎ (2 revisions)
  98. Thyroid blocking‏‎ (2 revisions)
  99. Curie‏‎ (2 revisions)
  100. Transparency‏‎ (2 revisions)

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)